FacultyFaculty/Author Profile
David K. Barr

David K. Barr

Arnold & Porter Kaye Scholer LLP

New York City, NY, USA


David K. Barr concentrates in the areas of patent, trade secret, and unfair competition litigation and counseling. Mr. Barr's experience includes litigation in federal and state courts, appeals to the Federal Circuit Court of Appeals and practice before the US Patent and Trademark Office, including contentious inter partes proceedings. Mr. Barr has been lead trial counsel in many complex Hatch-Waxman and biotech patent infringement cases, and has counseled clients on product development and strategic patent planning. He has extensive experience in intellectual property transactions, including licenses and acquisitions. Mr. Barr has also conducted numerous patent due diligence investigations, and has drafted patent license and related agreements. His patent matters have involved a variety of technologies, including biotechnology, pharmaceuticals, industrial chemistry and biomedical and mechanical devices.

Mr. Barr has authored articles and has lectured on a variety of intellectual property issues. He is a co-author and co-editor of the treatise Pharmaceutical and Biotech Patent Law (Practising Law Institute, 2016).

Mr. Barr received his law degree from the George Washington University Law School, where he was an Associate Editor of the George Washington Journal of International Law and Economics.

David K. Barr is associated with the following items:
Course Handbooks  Course Handbooks Developments in Pharmaceutical and Biotech Patent Law 2016
Developments in Pharmaceutical and Biotech Patent Law 2017
CHB Chapters  CHB Chapters Chapter 14 Biologic and Biosimilar Drug Products, prepublication revision, PLI Legal Treatise, Pharmaceutical and Biotech Patent Law - Developments in Pharmaceutical and Biotech Patent Law 2016, Monday, December 12, 2016
Ch. 14: Biologic and Biosimilar Drug Products, Practising Law Institute, Pharmaceutical and Biotech Patent Law (Prepublication Revision) (August 2017) - Developments in Pharmaceutical and Biotech Patent Law 2017, Wednesday, November 01, 2017
Web Segment  Web Segment Biosimilars Litigation at the Supreme Court, Federal Circuit, and District Court Levels - Developments in Pharmaceutical and Biotech Patent Law 2017, Thursday, November 02, 2017
MP3 Audio  MP3 Audio Biosimilars Litigation at the Supreme Court, Federal Circuit, and District Court Levels - Biosimilars Litigation at the Supreme Court, Federal Circuit, and District Court Levels, Thursday, November 02, 2017
Transcripts  Transcripts Biosimilars Litigation at the Supreme Court, Federal Circuit, and District Court Levels - Biosimilars Litigation at the Supreme Court, Federal Circuit, and District Court Levels, Thursday, November 02, 2017
MP4 - Mobile Video Seg  MP4 - Mobile Video Seg Biosimilars Litigation at the Supreme Court, Federal Circuit, and District Court Levels - Biosimilars Litigation at the Supreme Court, Federal Circuit, and District Court Levels, Thursday, November 02, 2017
On-Demand Web Programs  On-Demand Web Programs Developments in Pharmaceutical and Biotech Patent Law 2017, Monday, November 06, 2017, New York, NY
Treatise Chapters  Treatise Chapters Biologic and Biosimilar Drug Products - Pharmaceutical and Biotech Patent Law, Monday, November 13, 2017
A Brief Introduction to the United States Patent System - Pharmaceutical and Biotech Patent Law, Monday, November 13, 2017
Patent Infringement - Pharmaceutical and Biotech Patent Law, Monday, November 13, 2017
Types of Biological and Pharmaceutical Patents - Pharmaceutical and Biotech Patent Law, Monday, November 13, 2017
Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • GooglePlus
  • RSS

All Contents Copyright © 1996-2017 Practising Law Institute. Continuing Legal Education since 1933.

© 2017 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.